Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Tafamidis
Strength: 61 mg
Dosage form: cápsula blanda
Route: vía oral
Register: Spain (AEMPS)
Status: Authorised
Status in the register: Autorizado, no comercializado
Authorised: 5 Oct 2026
Registration: 1110717003IP
Marketing authorisation holder: Pfizer Europe Ma Eeig
Procedure: EU centralised
Supply: Uso Hospitalario

Tafamidis Accord 61 MG Capsulas Blandas EfgTafamidis · 61 mg · cápsula blandaSpain

Tafamidis Aurovitas 20 MG Capsulas Blandas EfgTafamidis · 20 mg · cápsula blandaSpain

Tafamidis Cinfa 20 MG Cápsulas Blandas EfgTafamidis · 20 mg · cápsula blandaSpain

Tafamidis Stada 61 MG Capsulas Blandas EfgTafamidis · 61 mg · cápsula blandaSpain

Tafamidis Viatris 61 MG Capsulas Blandas EfgTafamidis · 61 mg · cápsula blandaSpain

Tafamidis Zentiva 61 MG Capsulas Blandas EfgTafamidis · 61 mg · cápsula blandaSpain

Vyndaqel 20 MG Capsulas BlandasTafamidis · 20 mg · cápsula blandaSpain